GPX1 — Glutathione Peroxidase 1

GPX1 — Glutathione Peroxidase 1

Introduction

GPX1 (Glutathione Peroxidase 1) is one of the most critical antioxidant enzymes in mammalian cells and plays a central role in protecting neurons from oxidative damage. As a selenoprotein, GPX1 requires selenium for its activity and catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to water and corresponding alcohols, using glutathione (GSH) as the electron donor[@bellinger2011].

GPX1 is among the most studied antioxidant enzymes in neurodegenerative disease research due to its central role in mitigating oxidative stress, a hallmark of Alzheimer's disease, Parkinson's disease, and related disorders.

GPX1 — Glutathione Peroxidase 1

Introduction

GPX1 (Glutathione Peroxidase 1) is one of the most critical antioxidant enzymes in mammalian cells and plays a central role in protecting neurons from oxidative damage. As a selenoprotein, GPX1 requires selenium for its activity and catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to water and corresponding alcohols, using glutathione (GSH) as the electron donor[@bellinger2011].

GPX1 is among the most studied antioxidant enzymes in neurodegenerative disease research due to its central role in mitigating oxidative stress, a hallmark of Alzheimer's disease, Parkinson's disease, and related disorders.

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GPX1 — Glutathione Peroxidase 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GPX1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutathione Peroxidase 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/2783" target="_blank">2783</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000133247" target="_blank">ENSG00000133247</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/138320" target="_blank">138320</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P07203" target="_blank">P07203</a></td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>Selenoprotein, Antioxidant enzyme</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>22.5 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Location</td>
<td>Cytosol, Mitochondria</td>
</tr>
<tr>
<td class="label">Cofactor</td>
<td>Selenium (selenocysteine)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">100 edges</a></td>
</tr>
</table>

GPX1 — Glutathione Peroxidase 1

Overview

GPX1 (Glutathione Peroxidase 1) is a gene located on chromosome 3p21.31 that encodes a selenoprotein enzyme crucial for cellular antioxidant defense. GPX1 catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and corresponding alcohols, using glutathione as the electron donor["@zhang2015"].

GPX1 is one of the most abundant selenoproteins in mammals and plays a central role in protecting cells from oxidative damage. The enzyme operates in the cytosol and mitochondria, providing broad antioxidant protection throughout the cell.

Gene Structure and Regulation

Genomic Organization

• Location: 3p21.31 (chr3: 49,310,500-49,315,700, GRCh38)
• Gene length: ~5.2 kb
• Exons: 2 coding exons
• mRNA length: 654 bp (NM_000581)
• Protein length: 203 amino acids

Selenocysteine Insertion

GPX1 contains a selenocysteine (Sec) residue at position 46 (UGA codon), which is essential for catalytic activity. This requires:

Transcriptional Regulation

GPX1 expression is regulated by multiple factors:

| Factor | Effect | Mechanism |
|--------|--------|----------|
| Nrf2 | Activation | Antioxidant response elements (ARE) |
| p53 | Activation | Direct binding to promoter |
| NF-κB | Repression | Transcriptional inhibition |
| Selenium availability | Activation | Translation regulation |
| Oxidative stress | Activation | ARE-mediated transcription |

Protein Structure and Function

Catalytic Mechanism

GPX1 catalyzes the following reaction:

2 GSH + ROOH → GSSG + H₂O + ROH

Where:

• GSH = reduced glutathione
• GSSG = oxidized glutathione
• ROOH = organic hydroperoxide

Structural Features

• N-terminal region: Dimerization interface
• Catalytic center: Selenocysteine at position 46
• GSH binding site: C-terminal region
• Substrate access channel: Central cavity

Subcellular Distribution

GPX1 localizes to:

• Cytosol: ~70% of total cellular GPX1
• Mitochondria: ~30% (targeted by alternative translation start)
• Nucleus: Small fraction (stress-induced)

Expression Patterns

Tissue Distribution

| Tissue | Expression | Notes |
|--------|------------|-------|
| Liver | Very high | Primary expression site |
| Kidney | High | High basal expression |
| Heart | High | Cardiac protection |
| Brain | Moderate | Neurons and glia |
| Erythrocytes | High | Circulating antioxidant |
| Lung | Moderate | Barrier protection |
| Skeletal muscle | Moderate | Exercise-responsive |

Brain Expression

In the central nervous system:

• Neurons: High expression in pyramidal neurons, Purkinje cells
• Astrocytes: Moderate expression
• Microglia: Lower expression, increases with activation
• Oligodendrocytes: Moderate expression

• Hippocampus: High
• Cerebral cortex: High
• Cerebellum: Moderate
• Substantia nigra: High (dopaminergic neurons)

Role in Cellular Processes

Antioxidant Defense

GPX1 is the primary enzyme for:

• Catalase-independent H₂O₂ removal
• Prevents hydroxyl radical formation

• Reduces lipid hydroperoxides
• Prevents ferroptosis
• Protects membrane integrity

• Prevents oxidative DNA damage
• Maintains genomic integrity

• Prevents oxidative protein damage
• Maintains enzyme function

Oxidative Stress Response

GPX1 is integral to cellular stress response:

ROS (H₂O₂) → GPX1 activation → Signal transduction
↓
Antioxidant gene activation (via Nrf2)
↓
Cellular adaptation to stress

Mitochondrial Function

GPX1 protects mitochondria from oxidative damage:

Disease Associations

Parkinson's Disease

GPX1 is significantly implicated in PD pathogenesis[@eskici2020]:

Pathological findings:

• GPX1 activity reduced by 40-60% in substantia nigra of PD patients
• GPX1 protein levels decreased in dopaminergic neurons
• Selenium levels reduced in PD brain

• alpha-synuclein toxicity: GPX1 protects against oxidative stress induced by alpha-synuclein aggregation
• Mitochondrial dysfunction: GPX1 deficiency exacerbates complex I damage
• Dopaminergic neuron vulnerability: High oxidative stress makes neurons particularly dependent on GPX1

• GPX1 Pro198Leu variant associated with PD risk in some populations
• GPX1 promoter polymorphisms affect expression

Alzheimer's Disease

GPX1 involvement in AD[@kim2021]:

Pathological changes:

• GPX1 activity reduced in AD hippocampus and cortex
• Inverse correlation with amyloid burden
• Correlation with cognitive decline

• Amyloid-beta toxicity: GPX1 protects against Aβ-induced oxidative stress
• Tau pathology: GPX1 reduction exacerbates tau hyperphosphorylation
• Neuroinflammation: GPX1 modulates microglial oxidative stress

Amyotrophic Lateral Sclerosis

ALS connections:

• Reduced GPX1 activity in motor neurons
• GPX1 overexpression delays disease onset in SOD1 mice
• Selenium deficiency accelerates disease progression
• Interaction with other antioxidant systems (SOD1, catalase)

Stroke and Ischemia

Ischemic injury:

• GPX1 provides neuroprotection against cerebral ischemia
• GPX1 knockout mice show larger infarcts
• Preconditioning induces GPX1 expression

• GPX1 critical for managing oxidative burst
• Overexpression protects against hemorrhagic transformation

Other Neurodegenerative Conditions

| Condition | GPX1 Status | Notes |
|-----------|-------------|-------|
| Huntington's disease | Reduced | In striatum |
| Multiple sclerosis | Variable | Active lesions reduced |
| Frontotemporal dementia | Reduced | Temporal cortex |
| Prion disease | Reduced | Prion-infected brain |

Therapeutic Implications

Selenium Supplementation

Selenium increases GPX1 expression and activity:

• Dietary selenium: Required for GPX1 synthesis
• Selenomethionine: Organic selenium, better absorption
• Selenite: Inorganic form, also effective

• Optimal dose: 50-200 μg/day
• Monitoring: GPX1 activity as biomarker
• Toxicity: Upper limit ~400 μg/day

Pharmacological Approaches

| Strategy | Compound | Stage |
|----------|----------|-------|
| GPX1 expression | Ebselen (selenium donor) | Clinical |
| GPX1 activity | Synthetic selenocompounds | Preclinical |
| Gene therapy | AAV-GPX1 | Preclinical |
| Small molecule | N-acetylcysteine (GSH precursor) | Clinical |

Lifestyle Interventions

Interaction with Other Proteins

Antioxidant Network

| Protein | Interaction | Function |
|---------|-------------|----------|
| SOD1 | Complementary | Primary antioxidant enzymes |
| Catalase | Complementary | H₂O₂ detoxification |
| Thioredoxin | Regeneration | Maintains reduced state |
| Glutathione reductase | Regeneration | Maintains GSH pool |
| Nrf2 | Regulation | Transcriptional activation |

Disease Protein Interactions

• alpha-synuclein: GPX1 protects against oxidative modifications
• Amyloid-beta: GPX1 reduces Aβ-induced ROS
• Tau: GPX1 mitigates oxidative stress in tauopathy
• SOD1: Cooperates in ALS models

Research Directions

Unresolved Questions

Emerging Research

• GPX1 and ferroptosis: New links to iron-dependent cell death
• Single-cell analysis: Cell-type specific GPX1 function
• Optogenetics: Light-controlled GPX1 activity

See Also

• [Glutathione System](/mechanisms/oxidative-stress)
• [GPX4 — Phospholipid Hydroperoxide GPX](/genes/gpx4)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)
• [Selenoproteins in Brain](/mechanisms/selenium-signaling)
• [Parkinson's Disease Pathogenesis](/mechanisms/pd-neuroinflammation-pathway)
• [Alzheimer's Disease Mechanisms](/mechanisms/ad-neuroinflammation-microglia-pathway)
• [Ferroptosis in Neurodegeneration](/mechanisms/ferroptosis-neurodegeneration)
• [Glutathione Metabolism Pathway](/mechanisms/glutathione-metabolism)
• [Nrf2 Antioxidant Pathway](/mechanisms/nrf2-signaling)

Additional Content

GPX1 and the Selenocysteine Code

The "selenocysteine code" refers to the specialized machinery required to incorporate the 21st amino acid, selenocysteine (Sec), into proteins. GPX1 exemplifies this complexity:

Sec vs. Cysteine:

• [Sec has lower pKa (5.2 vs 8.3), making it a better nucleophile](/institutions/ucl)
• Sec has higher reduction potential, making it more reactive
• Sec is more susceptible to oxidative damage (paradoxical)

Regulation by selenium:

• Selenium availability directly affects GPX1 translation
• Low selenium reduces GPX1 without affecting other selenoproteins
• Different selenoproteins have different selenium thresholds

GPX1 in Cellular Senescence

Cellular senescence is characterized by irreversible cell cycle arrest and secretory phenotype (SASP). GPX1 plays a role in senescence:

Senescence-associated changes:

• GPX1 activity decreases in senescent cells
• This contributes to ROS accumulation and SASP
• Overexpression of GPX1 delays senescence onset

• GPX1 modulators could influence aging
• Senolytic strategies might target GPX1-low cells
• Antioxidant interventions could modify SASP

GPX1 in Neurogenesis

GPX1 affects neural stem cell function:

• GPX1 is expressed in neural progenitor cells
• Supports proliferation through ROS management
• Differentiation requires GPX1 modulation
• Overexpression enhances neurogenesis in models

GPX1 and Blood-Brain Barrier

GPX1 protects the blood-brain barrier (BBB):

• Endothelial GPX1 maintains BBB integrity
• Oxidative stress disrupts BBB; GPX1 prevents this
• GPX1 deficiency increases BBB permeability
• Therapeutic potential for stroke and MS

GPX1 Polymorphisms and Disease Risk

Several GPX1 polymorphisms have been studied:

| Polymorphism | Effect | Disease Association |
|--------------|--------|---------------------|
| Pro198Leu | Reduced activity | PD risk (some populations) |
| -602A>G | Altered expression | AD risk |
| Codon 5 variants | Variable | Cardiovascular disease |
| 3' UTR variants | mRNA stability | Cancer risk |

Measuring GPX1 Activity

Several methods exist to assess GPX1:

Clinical and research applications:

• Biomarker for oxidative stress
• Response to selenium supplementation
• Disease progression marker
• Therapeutic efficacy marker

External Links

• [NCBI Gene: GPX1](https://www.ncbi.nlm.nih.gov/gene/2783)
• [UniProt: GPX1](https://www.uniprot.org/uniprot/P07203)
• [Ensembl: GPX1](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000133247)
• [Selenoprotein Database](https://selenodb.org/)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving GPX1 — Glutathione Peroxidase 1 discovered through SciDEX knowledge graph analysis: